Systematix Corporate Services invests ₹10 crore in subsidiary via rights issue
- Systematix Corporate Services invested ₹10 crore in wholly owned subsidiary SWASPL via rights issue
- Funds are allocated for working capital requirements of the subsidiary
- SWASPL's turnover grew from nil in FY25 to ₹193.06 lakh in FY26
- Transaction involves subscription of 1 crore equity shares at par value of ₹10 each

*this image is generated using AI for illustrative purposes only.
Systematix Corporate Services has invested ₹10 crore in its wholly owned subsidiary Systematix Wealth & Asset Services Private Limited (SWASPL) through a rights issue, with the proceeds designated for working capital purposes.
Investment details
The following table summarises the key parameters of the transaction:
| Parameter | Details |
|---|---|
| Investee entity | Systematix Wealth & Asset Services Private Limited (SWASPL) |
| Relationship | Wholly owned subsidiary |
| Investment amount | ₹10 crore |
| Mode of investment | Rights issue |
| Purpose | Working capital |
The investment was made by Systematix Corporate Services into SWASPL via a rights issue, a mechanism that allows an existing shareholder to subscribe to additional shares in proportion to their holding. As the sole shareholder of SWASPL, Systematix Corporate Services subscribed to 1 crore equity shares of face value ₹10 each at par, aggregating to ₹10 crore. The transaction is a cash consideration and falls within the ambit of related party transactions, conducted at arm's length.
Subsidiary profile and financials
SWASPL, formerly known as Systematix Wealth & Asset Management Private Limited and Systematix Ventures Private Limited, operates in the capital markets sector. The entity focuses on Alternative Investment Funds, wealth management, and distribution services for various financial products. It holds registrations from the Association of Mutual Funds in India (AMFI) and the Securities and Exchange Board of India (SEBI) as a Portfolio Manager.
The subsidiary's financial trajectory shows significant recent growth after a dormant period. The following table details the turnover for the last three fiscal years:
| Fiscal Year | Turnover (₹ lakh) |
|---|---|
| FY24 | 0.02 |
| FY25 | Nil |
| FY26 | 193.06 |
Use of proceeds
The funds infused through this rights issue are earmarked specifically for working capital requirements of SWASPL. Working capital funding supports the day-to-day operational needs of a business, including the management of short-term assets and liabilities. The company stated that there will be no change in the percentage of shareholding, with SWASPL continuing to remain a wholly owned subsidiary.
What the numbers show
The infusion of ₹10 crore contrasts sharply with SWASPL's reported turnover of ₹193.06 lakh (approximately ₹1.93 crore) for FY26. This indicates that the capital injection is roughly five times the subsidiary's annual revenue, suggesting a strategic capitalization effort to support future scaling or operational stability rather than immediate liquidity needs based on current revenue levels. The jump from nil turnover in FY25 to ₹193.06 lakh in FY26 marks a significant operational restart or expansion phase for the subsidiary.
Historical Stock Returns for Systematix Corporate Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.78% | +3.25% | +6.17% | +6.56% | -50.32% | -46.08% |
How will the ₹10 crore working capital infusion specifically accelerate SWASPL's growth in the Alternative Investment Funds and wealth management segments?
What is the expected timeline for Systematix Corporate Services to achieve a return on investment given the subsidiary's current revenue base of ₹1.93 crore?
Are there plans for further capital injections or external fundraising for SWASPL to support its operational scaling beyond this initial rights issue?


































